awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49818975-90E70C21-86E4-4B52-8808-E58952039DDE
Q49818975-90E70C21-86E4-4B52-8808-E58952039DDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49818975-90E70C21-86E4-4B52-8808-E58952039DDE
The siren song of bevacizumab: swan song or clarion call?
P2860
Q49818975-90E70C21-86E4-4B52-8808-E58952039DDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49818975-90E70C21-86E4-4B52-8808-E58952039DDE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ea8ec51c61560b2ebe057502ec37d6777d0a756
P2860
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.